Bhaskaran NA - Search Results

1

Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats.

Gourishetti K, Keni R, Nayak PG, Jitta SR, Bhaskaran NA, Kumar L, Kumar N, Krishnadas N, Shenoy RR. Gourishetti K, et al. Among authors: bhaskaran na. Int J Nanomedicine. 2020 Nov 23;15:9265-9282. doi: 10.2147/IJN.S268941. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33262587 Free PMC article.

2

An analytical "quality by design" approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation.

Bhaskaran NA, Kumar L, Reddy MS, Pai GK. Bhaskaran NA, et al. Acta Pharm. 2021 Mar 1;71(1):57-79. doi: 10.2478/acph-2021-0008. Acta Pharm. 2021. PMID: 32697749 Free article.

3

Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems.

Bhaskaran NA, Kumar L. Bhaskaran NA, et al. J Control Release. 2021 Aug 10;336:16-39. doi: 10.1016/j.jconrel.2021.06.008. Epub 2021 Jun 9. J Control Release. 2021. PMID: 34118336 Review.

4

Anti-oxidant Containing Nanostructured Lipid Carriers of Ritonavir: Development, Optimization, and In Vitro and In Vivo Evaluations.

Jitta SR, Bhaskaran NA, Salwa, Kumar L. Jitta SR, et al. Among authors: bhaskaran na. AAPS PharmSciTech. 2022 Mar 16;23(4):88. doi: 10.1208/s12249-022-02240-w. AAPS PharmSciTech. 2022. PMID: 35296970

5

Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: Preparation, in-vitro and in-vivo evaluations.

Bhaskaran NA, Jitta SR, Salwa, Cheruku S, Kumar N, Kumar L. Bhaskaran NA, et al. Int J Biol Macromol. 2022 Jun 30;211:301-315. doi: 10.1016/j.ijbiomac.2022.05.060. Epub 2022 May 12. Int J Biol Macromol. 2022. PMID: 35568152

6

Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS.

Jitta SR, Salwa, Bhaskaran NA, Marques SM, Kumar L. Jitta SR, et al. Among authors: bhaskaran na. Expert Opin Drug Deliv. 2022 Sep;19(9):1133-1148. doi: 10.1080/17425247.2022.2121817. Epub 2022 Sep 8. Expert Opin Drug Deliv. 2022. PMID: 36063032 Review.

7

Enhanced tissue distribution of ritonavir-loaded nanostructured lipid carriers-recommending its dose reduction.

Jitta SR, Salwa, Bhaskaran NA, Marques SM, Kumar L, Cheruku SP, Rao V, Sharma P, Kulkarni OP. Jitta SR, et al. Among authors: bhaskaran na. Drug Deliv Transl Res. 2024 Jan;14(1):116-130. doi: 10.1007/s13346-023-01386-9. Epub 2023 Jul 4. Drug Deliv Transl Res. 2024. PMID: 37402943

8

Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer.

Bhaskaran NA, Jitta SR, Salwa, Kumar L, Sharma P, Kulkarni OP, Hari G, Gourishetti K, Verma R, Birangal SR, Bhaskar KV. Bhaskaran NA, et al. Int J Biol Macromol. 2023 Dec 31;253(Pt 5):127142. doi: 10.1016/j.ijbiomac.2023.127142. Epub 2023 Oct 4. Int J Biol Macromol. 2023. PMID: 37797853

9

Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent-loaded nanoparticles.

Siddiquee T, Bhaskaran NA, Nathani K, Sawarkar SP. Siddiquee T, et al. Among authors: bhaskaran na. Phytother Res. 2024 Aug;38(8):3899-3920. doi: 10.1002/ptr.8241. Epub 2024 May 28. Phytother Res. 2024. PMID: 38806412 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters